Michael Barry

Hospitals are being offered a €500 incentive for every patient they move off two expensive high-tech medicines and on to cheaper alternatives, in the (...)

Health authorities in England and Wales have approved the use of the drug Spinraza, leaving Ireland, with Estonia, as the only EU states barring acces(...)

The Government and pharmaceutical companies need to fundamentally reform the approach to setting medicine prices, a spokesman for the major drug compa(...)

It could cost the State up to €500 million to provide public patients with wider access to innovative new cancer therapies in the same way health insu(...)

Commercial rivals to the VHI say they have no plans to follow the semi-State health insurer’s lead by providing wider access to cancer drugs for some (...)

Spiralling drug costs threaten to bankrupt healthcare systems and deny patients access to essential medicines, according to lobby group Access to Medi(...)

Ten new medicines approved for use by the Health Service Executive last week have been waiting for more than two years on average for sanction, accord(...)

Access to medicines is always an emotive issue. If you’re a patient with a life-limiting condition, you’ll never understand why you cannot access a dr(...)

Pharmaceutical companies have rejected allegations that they are pursuing “predatory pricing” for new medicines. The Irish Pharmaceutical Healthcare (...)

Women with cervical cancer will get access to a potentially life-saving drug under new plans being brought forward by the Minister for Health. “Pemb(...)